Table 3.
Univariate analysis—progression-free survival (PFS).
| Variable | HR | 95% CI | P value |
|---|---|---|---|
| Sex (male) | 0.6 | 0.2-1.8 | 0.38 |
| Age | 1 | 0.94-1.1 | 0.92 |
| Heavy chain (IgG) | 1.7 | 0.53-5.64 | 0.35 |
| Light chain (k) | 0.79 | 0.26-2.4 | 0.68 |
| Years from diagnosis | 0.92 | 0.77-1.1 | 0.38 |
| Prior therapy lines | 1.07 | 0.88-1.32 | 0.47 |
| M-protein | 1.1 | 0.81-1.51 | 0.51 |
| OR (yes) | 0.11 | 0.03-0.46 | <0.05 |
| VGPR or better (yes) | 0.01 | 0-143 | 0.35 |
| GFR ≥40 ml/min (yes) | 0.91 | 0.25-3.35 | 0.89 |
HR, hazard ratio; CI, confidential interval; IgG, immunoglobulin G; OR, overall response; VGPR, very good partial remission; GFR, glomerular filtration rate.
(N = 28).